Hindson Benjamin J. 4

What Happened
Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics (TXG), disposed of 11,595 shares on May 22, 2026. The shares were sold at $24.44 each for total proceeds of approximately $283,399. The filing indicates the sale was to cover tax withholding obligations related to the vesting of restricted stock units (RSUs), making this a routine, tax-related disposition rather than a standalone investment sell signal.

Key Details

• Transaction date and price: 2026-05-22 — 11,595 shares sold at $24.44 per share (total ~$283,399).
• Transaction type/code: S (Sale). Footnote F1: shares sold to cover tax withholding from RSU vesting.
• Shares owned after transaction: Not disclosed in this Form 4 filing.
• Filing date: 2026-05-27 for a 2026-05-22 transaction — the report appears to have been filed late by one business day.

Context

• This was a tax-withholding sale tied to RSU vesting (common practice); such sales are routine and don't necessarily reflect the insider's view on the company.
• No options were exercised, no purchases or gifts were reported in this transaction, and no 10b5-1 plan was indicated.